Abstract:BACKGROUND:The new tetrandrine derivative is an anti-human liver cancer cell inhibitor which can be used to design and develop anti-human-liver-cancer drugs.OBJECTIVE:A quantitative structure-activity relationship (QSAR) model was established to predict the physical properties of new tetrandrine derivatives using their chemical structures.METHODS:The best descriptors were selected through CODESSA software to build a multiple linear regression model. Then, gene expression programming (GEP) was used to establish a nonlinear quantitative QSAR model with descriptors to predict the activity of a series of novel tetrandrine chemotherapy drugs. The best active compound 31 was subjected to molecular docking experiments through SYBYL software with a small fragment of the protein receptor (PDB ID:2J6M).RESULTS:Four descriptors were selected to build a multiple linear regression model with correlation coefficients R2, R2CV and S2 with the values of 0.8352, 0.7806 and 0.0119, respectively. The training and test sets with a correlation coefficient of 0.85 and 0.83 were obtained via an automatic problem-solving program (APS) using the four selected operators as parameters, with a mean error of 1.49 and 1.08. Compound 31 had a good docking ability with an overall score of 5.8892, a collision rate of -2.8004 and an extreme value of 0.9836.CONCLUSION:The computer-constructed drug molecular model reveals the factors affecting the activity of human hepatocellular carcinoma cells, which provides directions and guidance for the development of highly effective anti-humanhepatocellular- carcinoma drugs in the future.

QSAR study of fiavonoids derivatives as p56lck protein tyrosine kinase inhibitors using GA-SVM

A novel tree kernel support vector machine classifier for modeling the relationship between bioactivity and molecular descriptors

QSAR Research of Novel Tetrandrine Derivatives Against Human Hepatocellular Carcinoma.

Using support vector regression for QSAR study on the aldose reductase inhibitory activity of some flavones

Quantitative Structure–activity Relationship: Promising Advances in Drug Discovery Platforms

QSAR study of flavonoids inhibitors of the PIM-1 kinase

3D-QSAR Study on 2,3-Dihydroimidazo[4,5]-pyridin-2-one Derivatives with a Meta Substitution Pattern As V600E BRAF Inhibitors

Prediction of the Aquatic Toxicity of Aromatic Compounds to Tetrahymena Pyriformis Through Support Vector Regression

QSAR Studies of Imidazopyridine Derivatives As Et-PKG Inhibitors Using the PSO-SVM Approach

Using Support Vector Regression Coupled with the Genetic Algorithm for Predicting Acute Toxicity to the Fathead Minnow

QSAR study of Akt/protein kinase B (PKB) inhibitors using support vector machine.

Classification of Src Kinase Inhibitors Based on Support Vector Machine

QSAR analysis of VEGFR-2 inhibitors based on machine learning, Topomer CoMFA and molecule docking

Kernel-based partial least squares: application to fingerprint-based QSAR with model visualization

Applications of Genetic Algorithms on the Structure–activity Correlation Study of a Group of Non-Nucleoside HIV-1 Inhibitors

3D-QSAR Study for Inhibitors of Cyclin-Dependent Kinase 4

QSAR Studies on 1-Aryl-tetrahydroisoquinoline Analogs As Active Anti-HIV Agents Based on PSO-v-SVM

Quantitative Structure–activity Relationship Study of Influenza Virus Neuraminidase A/PR/8/34 (H1N1) Inhibitors by Genetic Algorithm Feature Selection and Support Vector Regression

A novel non-linear approach for establishing a QSAR model of a class of 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivatives

QSAR study of cinnamylphenol derivatives as EBV-EA inhibitors

3D-QSAR study on the inhibitory activity of flavonoids on PIM-1 kinase